SS
Swarn Singh
About Swarn Singh
Data last updated:
Swarn Singh is a Director at Acekinetics Healthcare Private Limited (since 2009), Director at Sarcoma Remedies Private Limited (since 2015) and Director at Swakam Biotech Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, Chemicals and FMCG. The 5 current companies with reported revenue have a combined latest revenue of ₹17.04 Cr; the largest is Acekinetics Healthcare Private Limited at ₹9.95 Cr (FY 2025). Earlier, Swarn Singh was a Director at Naviksha Healthcare Private Limited (2021–2023) and Additional Director at Innovative Lifesciences Private Limited (2014–2015) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Acekinetics Healthcare Private Limited U24299CH2009PTC031796 | Director | 30 Dec 2009 | 2009 | ₹9.95 Cr (FY 2025) | Active |
 Sarcoma Remedies Private Limited U24239CH2015PTC035704 | Director | 21 Aug 2015 | 2015 | ₹3.65 Cr (FY 2025) | Active |
 Swakam Biotech Private Limited U24299CH2021PTC043504 | Director | 16 Feb 2021 | 2021 | ₹2.35 Cr (FY 2025) | Active |
 Jayden Healthcare Private Limited U24239CH2019PTC042798 | Director | 26 Nov 2019 | 2019 | ₹80.2 Lakh (FY 2025) | Active |
| Medimore Healthcare Private Limited U24239HR2022PTC102815 | Director | 13 Apr 2022 | 2022 | ₹29.7 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Naviksha Healthcare Private Limited U24110CH2021PTC043517 | Director | 24 Feb 2021 | 2021 | ₹2.49 Cr (FY 2025) | Active |
 Innovative Lifesciences Private Limited U24232HR2012PTC065919 | Additional Director | 18 Dec 2014 | 2012 | ₹12.51 Cr (FY 2021) | Active |
 Dermia Conticare Private Limited U24232CH2015PTC035853 | Director | 14 Dec 2015 | 2015 | ₹2.99 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Swarn Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Seema | 09351215 | Acekinetics Healthcare Private Limited , Medimore Healthcare Private Limited | Director |
| Ankit Kumar | 09067013 | Sarcoma Remedies Private Limited | Director |
| Narendra Kumar | 07253044 | Sarcoma Remedies Private Limited | Director |
| Ravinder Singh | 09068612 | Swakam Biotech Private Limited | Director |
| Ashwani Kumar | 08622493 | Jayden Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swarn Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swarn Singh
Swarn Singh currently holds 5 directorships: Acekinetics Healthcare Private Limited (Director, since 30 Dec 2009, revenue ₹9.95 Cr (FY 2025)); Sarcoma Remedies Private Limited (Director, since 21 Aug 2015, revenue ₹3.65 Cr (FY 2025)); Swakam Biotech Private Limited (Director, since 16 Feb 2021, revenue ₹2.35 Cr (FY 2025)); Jayden Healthcare Private Limited (Director, since 26 Nov 2019, revenue ₹80.2 Lakh (FY 2025)); Medimore Healthcare Private Limited (Director, since 13 Apr 2022, revenue ₹29.7 Lakh (FY 2024)).
Swarn Singh was first appointed on 30 Dec 2009 as Director at Acekinetics Healthcare Private Limited. The most recent appointment on record is 13 Apr 2022 at Medimore Healthcare Private Limited.
The 5 current companies of Swarn Singh that report revenue have a combined latest revenue of ₹17.04 Cr: Acekinetics Healthcare Private Limited ₹9.95 Cr (FY 2025); Sarcoma Remedies Private Limited ₹3.65 Cr (FY 2025); Swakam Biotech Private Limited ₹2.35 Cr (FY 2025); Jayden Healthcare Private Limited ₹80.2 Lakh (FY 2025); Medimore Healthcare Private Limited ₹29.7 Lakh (FY 2024).
Swarn Singh held 3 earlier board appointments: Naviksha Healthcare Private Limited (Director, 24 Feb 2021 to 07 Apr 2023); Innovative Lifesciences Private Limited (Additional Director, 18 Dec 2014 to 22 Sep 2015); Dermia Conticare Private Limited (Director, 14 Dec 2015 to 19 Sep 2017).
The current boards of Swarn Singh's companies include Seema (Acekinetics Healthcare Private Limited), Ankit Kumar (Sarcoma Remedies Private Limited), Narendra Kumar (Sarcoma Remedies Private Limited), Ravinder Singh (Swakam Biotech Private Limited), Ashwani Kumar (Jayden Healthcare Private Limited).